Avalo Therapeutics to Participate in Upcoming Investor Conferences - Avalo Therapeutics ( NASDAQ:AVTX )
WAYNE, Pa. and ROCKVILLE, Md., Feb. 24, 2025 ( GLOBE NEWSWIRE ) -- Avalo Therapeutics, Inc. AVTX, a clinical stage biotechnology company focused on the treatment of immune dysregulation, today announced that management will participate in the following investor conferences in March.
Rapport Therapeutics to Participate in Upcoming Investor Conferences - Rapport Therapeutics ( NASDAQ:RAPP )
BOSTON and SAN DIEGO, Feb. 24, 2025 ( GLOBE NEWSWIRE ) -- Rapport Therapeutics, Inc.
Syndax to Announce Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call and Webcast on March 3, 2025
WALTHAM, Mass., Feb. 24, 2025 ( GLOBE NEWSWIRE ) -- Syndax Pharmaceuticals ( Nasdaq: SNDX ) , a commercial-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that it will report its fourth quarter and full year 2024 financial results and ...
JPMorgan Announces Cash Distributions for the JPMorgan ETFs
TORONTO, Feb. 24, 2025 ( GLOBE NEWSWIRE ) -- J. P. Morgan Asset Management ( JPMAM ) * today announced the final February 2025 cash distributions for the below listed JPMorgan ETFs. The JPMorgan ETFs trade on the Toronto Stock Exchange ( TSX ) .
3 Magnificent S&P 500 Dividend Stocks Down 36% to 64% to Buy and Hold Forever
The majority of the market isn't seeing the bigger picture for these stocks and their underlying companies. Big mistake.
Apellis Pharmaceuticals to Present at the TD Cowen 45th Annual Health Care Conference
WALTHAM, Mass., Feb. 24, 2025 ( GLOBE NEWSWIRE ) -- Apellis Pharmaceuticals, Inc. ( Nasdaq: APLS ) today announced that the company will present at the TD Cowen 45th Annual Health Care Conference on Monday, March 3, 2025, at 10:30 a.m. ET.
Skye Bioscience to Participate in SXSW Session on Obesity
SAN DIEGO, Feb. 24, 2025 ( GLOBE NEWSWIRE ) -- Skye Bioscience, Inc. ( Nasdaq: SKYE ) ( "Skye" ) , a clinical-stage biopharmaceutical company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders, is pleased to announce the participation of Punit Dhillon, ...
Beam Therapeutics to Participate in Upcoming March 2025 Investor Conferences - Beam Therapeutics ( NASDAQ:BEAM )
CAMBRIDGE, Mass., Feb. 24, 2025 ( GLOBE NEWSWIRE ) -- Beam Therapeutics Inc. BEAM, a biotechnology company developing precision genetic medicines through base editing, today announced that management will participate in fireside chats at the following upcoming investor conferences:
JPMorgan Announces Cash Distributions for the JPMorgan ETFs
TORONTO, Feb. 24, 2025 ( GLOBE NEWSWIRE ) -- J. P. Morgan Asset Management ( JPMAM ) * today announced the final February 2025 cash distributions for the below listed JPMorgan ETFs. The JPMorgan ETFs trade on the Toronto Stock Exchange ( TSX ) .
